This inventor holds 1 USPTO granted patent. Top assignees: Generation Biotech, Princeton University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015
Title: Gary Leroy - Innovator in DNA-Bound Protein Analysis
Introduction
Gary Leroy is an accomplished inventor based in Neptune, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the extraction and analysis of DNA-bound proteins. His innovative work has implications for understanding human diseases, including cancer.
Latest Patents
Gary Leroy holds a patent for a technology titled "Sequence-specific extraction and analysis of DNA-bound proteins." This automated protein preparation technology utilizes magnetic microparticles to isolate proteins in their native state from specific genomic loci of interest via the chromatin to which they are bound. After extraction, the targeted proteins can be purified for downstream analysis by quantitative mass spectrometry or ELISA. The identification of DNA-bound proteins, histones, and their post-translational modifications is crucial due to their role in the causation and development of human diseases, particularly cancer. He has 1 patent to his name.
Career Highlights
Throughout his career, Gary Leroy has worked with notable organizations, including Generation Biotech and Princeton University. His experience in these institutions has allowed him to develop and refine his innovative technologies.
Collaborations
Gary has collaborated with esteemed colleagues such as Benjamin Garcia and Johannes Dapprich. Their combined expertise has contributed to advancements in the field of protein analysis.
Conclusion
Gary Leroy's work in the extraction and analysis of DNA-bound proteins represents a significant advancement in biotechnology. His innovative approaches have the potential to enhance our understanding of critical health issues, particularly in cancer research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile